Literature DB >> 11698989

Prevalence and clinical manifestations of disseminated Mycobacterium avium complex infection in South Africans with acquired immunodeficiency syndrome.

C A Pettipher1, A S Karstaedt, M Hopley.   

Abstract

In a sample of 100 hospitalized human immunodeficiency virus-seropositive black South African patients with CD4 cell counts of <100 cells/mm(3), the point prevalence of disseminated Mycobacterium avium complex infection was 10%, in contrast with other African studies that report that the infection is uncommon. The point prevalence of Mycobacterium tuberculosis was 54%. The clinical and laboratory features of these patients were largely unhelpful in detecting M. avium complex; the BACTEC blood culture (Becton Dickinson) was the only reliable method.

Entities:  

Mesh:

Year:  2001        PMID: 11698989     DOI: 10.1086/323979

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  The usefulness of PCR assay in diagnosing disseminated mycobacterial infection in AIDS patients.

Authors:  L Gazzola; F Zanini; P Zerbi; F Franzetti; A Gori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-13       Impact factor: 3.267

Review 2.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  The role of speciation in positive Lowenstein-Jensen culture isolates from a high tuberculosis burden country.

Authors:  William Worodria; Jillian Anderson; Adithya Cattamanchi; J Lucian Davis; Saskia den Boon; Alfred Andama; Samuel D Yoo; Moses Joloba; Laurence Huang; Midori Kato-Maeda
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

4.  Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.

Authors:  Clare L van Halsema; Violet N Chihota; Nicolaas C Gey van Pittius; Katherine L Fielding; James J Lewis; Paul D van Helden; Gavin J Churchyard; Alison D Grant
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

5.  Nontuberculous mycobacteria immune reconstitution syndrome.

Authors:  J C Mogambery; A Motala; K Padayachee; C Jozi; H Dawood
Journal:  Case Rep Med       Date:  2014-11-11

Review 6.  Non-tuberculous mycobacteria pulmonary disease: A review of trends, risk factors, diagnosis and management.

Authors:  L Nqwata; A R Ouédrago
Journal:  Afr J Thorac Crit Care Med       Date:  2022-07-15

7.  Clinical relevance of nontuberculous Mycobacteria, Oman.

Authors:  Sara H Al-Mahruqi; Jakko van-Ingen; Suleiman Al-Busaidy; Martin J Boeree; Samiya Al-Zadjali; Arti Patel; P N Richard-Dekhuijzen; Dick van-Soolingen
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.